Mankind Pharma Limited (MANKIND) — Voting Results | 18 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Shareholders to vote on appointing Anish Vanraj Bafna as Non-Executive Independent Director via e-voting
💡 Investor Takeaway
Shareholders must approve the new director appointment through a special resolution by September 21, 2026.

Mankind Pharma Limited announced a postal ballot notice seeking shareholder approval via e-voting for the appointment of Mr. Anish Vanraj Bafna as a Non-Executive Independent Director. The voting period runs from August 19 to September 17, 2026, with results declared by September 21. The notice complies with SEBI, MCA, and Companies Act regulations, and outlines e-voting procedures through NSDL and CDSL platforms.

📄 View Original Announcement (PDF)

About Mankind Pharma Limited (MANKIND)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹97,467.05 Cr P/E: 47.7 ROE: 12.7% ROCE: 13.9% Div Yield: 0.04%

View full MANKIND stock details →

📡 Get AI alerts when MANKIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANKIND — Free

📊 More MANKIND filings

See all MANKIND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MANKIND files new disclosures

Track MANKIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANKIND — Free

Free account · 2 AI queries/day